annual cash & cash equivalents:
$482.05M-$263.32M(-35.33%)Summary
- As of today (June 16, 2025), DLB annual cash & cash equivalents is $482.05 million, with the most recent change of -$263.32 million (-35.33%) on September 27, 2024.
- During the last 3 years, DLB annual cash & cash equivalents has fallen by -$743.33 million (-60.66%).
- DLB annual cash & cash equivalents is now -60.66% below its all-time high of $1.23 billion, reached on September 24, 2021.
Performance
DLB Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$626.55M+$105.73M(+20.30%)Summary
- As of today (June 16, 2025), DLB quarterly cash & cash equivalents is $626.55 million, with the most recent change of +$105.73 million (+20.30%) on March 1, 2025.
- Over the past year, DLB quarterly cash & cash equivalents has dropped by -$82.98 million (-11.70%).
- DLB quarterly cash & cash equivalents is now -48.87% below its all-time high of $1.23 billion, reached on September 24, 2021.
Performance
DLB quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DLB Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -35.3% | -11.7% |
| 3 y3 years | -60.7% | -30.4% |
| 5 y5 years | -39.5% | -13.6% |
DLB Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.7% | at low | -27.1% | +30.0% |
| 5 y | 5-year | -60.7% | at low | -48.9% | +30.0% |
| alltime | all time | -60.7% | +2032.8% | -48.9% | +911.8% |
DLB Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $626.55M(+20.3%) |
| Dec 2024 | - | $520.82M(+8.0%) |
| Sep 2024 | $482.05M(-35.3%) | $482.05M(-35.0%) |
| Jun 2024 | - | $741.64M(+4.5%) |
| Mar 2024 | - | $709.53M(+8.0%) |
| Dec 2023 | - | $656.82M(-11.9%) |
| Sep 2023 | $745.36M(+20.2%) | $745.36M(-2.6%) |
| Jun 2023 | - | $765.08M(+11.1%) |
| Mar 2023 | - | $688.44M(+9.9%) |
| Dec 2022 | - | $626.16M(+1.0%) |
| Sep 2022 | $620.13M(-49.4%) | $620.13M(-27.8%) |
| Jun 2022 | - | $858.90M(-4.6%) |
| Mar 2022 | - | $900.39M(-14.8%) |
| Dec 2021 | - | $1.06B(-13.8%) |
| Sep 2021 | $1.23B(+14.3%) | $1.23B(+0.5%) |
| Jun 2021 | - | $1.22B(+10.4%) |
| Mar 2021 | - | $1.10B(-0.5%) |
| Dec 2020 | - | $1.11B(+3.6%) |
| Sep 2020 | $1.07B(+34.5%) | $1.07B(+25.4%) |
| Jun 2020 | - | $855.10M(+18.0%) |
| Mar 2020 | - | $724.93M(-2.2%) |
| Dec 2019 | - | $741.43M(-7.0%) |
| Sep 2019 | $797.21M(-13.2%) | $797.21M(+11.3%) |
| Jun 2019 | - | $716.56M(-1.4%) |
| Mar 2019 | - | $726.60M(-8.1%) |
| Dec 2018 | - | $790.79M(-13.9%) |
| Sep 2018 | $918.06M(+46.4%) | $918.06M(+10.7%) |
| Jun 2018 | - | $829.62M(+17.6%) |
| Mar 2018 | - | $705.52M(+18.3%) |
| Dec 2017 | - | $596.39M(-4.9%) |
| Sep 2017 | $627.02M(+21.5%) | $627.02M(+5.8%) |
| Jun 2017 | - | $592.62M(+11.3%) |
| Mar 2017 | - | $532.51M(+3.8%) |
| Dec 2016 | - | $512.84M(-0.6%) |
| Sep 2016 | $516.11M(-3.0%) | $516.11M(-14.0%) |
| Jun 2016 | - | $599.99M(+15.1%) |
| Mar 2016 | - | $521.20M(+11.6%) |
| Dec 2015 | - | $467.10M(-12.2%) |
| Sep 2015 | $531.93M(-6.4%) | $531.93M(+13.0%) |
| Jun 2015 | - | $470.87M(-8.4%) |
| Mar 2015 | - | $513.99M(+25.6%) |
| Dec 2014 | - | $409.12M(-28.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2014 | $568.47M(+25.1%) | $568.47M(-3.7%) |
| Jun 2014 | - | $590.10M(+3.7%) |
| Mar 2014 | - | $568.90M(+17.4%) |
| Dec 2013 | - | $484.64M(+6.7%) |
| Sep 2013 | $454.40M(-7.8%) | $454.40M(+11.2%) |
| Jun 2013 | - | $408.56M(+24.4%) |
| Mar 2013 | - | $328.51M(+3.9%) |
| Dec 2012 | - | $316.19M(-35.8%) |
| Sep 2012 | $492.60M(-10.7%) | $492.60M(-26.5%) |
| Jun 2012 | - | $670.41M(-10.4%) |
| Mar 2012 | - | $747.99M(+14.3%) |
| Dec 2011 | - | $654.41M(+18.7%) |
| Sep 2011 | $551.51M(+1.0%) | $551.51M(-7.2%) |
| Jun 2011 | - | $594.60M(+14.3%) |
| Mar 2011 | - | $520.27M(+20.0%) |
| Dec 2010 | - | $433.64M(-20.6%) |
| Sep 2010 | $545.86M(+20.9%) | $545.86M(+5.2%) |
| Jun 2010 | - | $519.10M(+24.4%) |
| Mar 2010 | - | $417.35M(+2.7%) |
| Dec 2009 | - | $406.24M(-10.1%) |
| Sep 2009 | $451.68M(+14.4%) | $451.68M(+24.3%) |
| Jun 2009 | - | $363.38M(-2.5%) |
| Mar 2009 | - | $372.53M(-7.4%) |
| Dec 2008 | - | $402.43M(+1.9%) |
| Sep 2008 | $394.76M(+7.1%) | $394.76M(+6.7%) |
| Jun 2008 | - | $369.91M(+6.4%) |
| Mar 2008 | - | $347.50M(+24.0%) |
| Dec 2007 | - | $280.25M(-23.9%) |
| Sep 2007 | $368.47M(-10.7%) | $368.47M(+13.1%) |
| Jun 2007 | - | $325.91M(-3.4%) |
| Mar 2007 | - | $337.40M(-17.6%) |
| Dec 2006 | - | $409.26M(-0.8%) |
| Sep 2006 | $412.49M(+10.8%) | $412.49M(+10.5%) |
| Jun 2006 | - | $373.42M(-17.1%) |
| Mar 2006 | - | $450.58M(+11.4%) |
| Dec 2005 | - | $404.50M(+8.6%) |
| Sep 2005 | $372.40M(+373.1%) | $372.40M(+3.0%) |
| Jun 2005 | - | $361.55M(+3.1%) |
| Mar 2005 | - | $350.65M(+272.7%) |
| Dec 2004 | - | $94.09M(+19.5%) |
| Sep 2004 | $78.71M(+27.1%) | $78.71M(+27.1%) |
| Sep 2003 | $61.92M(+174.0%) | $61.92M |
| Sep 2001 | $22.60M | - |
FAQ
- What is Dolby Laboratories annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Dolby Laboratories?
- What is Dolby Laboratories annual cash & cash equivalents year-on-year change?
- What is Dolby Laboratories quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Dolby Laboratories?
- What is Dolby Laboratories quarterly cash & cash equivalents year-on-year change?
What is Dolby Laboratories annual cash & cash equivalents?
The current annual cash & cash equivalents of DLB is $482.05M
What is the all time high annual cash & cash equivalents for Dolby Laboratories?
Dolby Laboratories all-time high annual cash & cash equivalents is $1.23B
What is Dolby Laboratories annual cash & cash equivalents year-on-year change?
Over the past year, DLB annual cash & cash equivalents has changed by -$263.32M (-35.33%)
What is Dolby Laboratories quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of DLB is $626.55M
What is the all time high quarterly cash & cash equivalents for Dolby Laboratories?
Dolby Laboratories all-time high quarterly cash & cash equivalents is $1.23B
What is Dolby Laboratories quarterly cash & cash equivalents year-on-year change?
Over the past year, DLB quarterly cash & cash equivalents has changed by -$82.98M (-11.70%)